Hemispherian Receives EUR 10 Million in Funding from the EIC Accelerator Program
The European Innovation Council (EIC) Accelerator grant application for Hemispherian AS (“Hemispherian” or the “Business”), a Norwegian preclinical pharmaceutical company focused on small molecule cancer GO→